165 related articles for article (PubMed ID: 37232235)
1. NT-proBNP and All-Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study.
Echouffo-Tcheugui JB; Zhang S; Daya N; McEvoy JW; Tang O; Juraschek SP; Ndumele CE; Coresh J; Christenson RH; Selvin E
J Am Heart Assoc; 2023 Jun; 12(11):e029110. PubMed ID: 37232235
[TBL] [Abstract][Full Text] [Related]
2. Subclinical Cardiovascular Disease in US Adults With and Without Diabetes.
Fang M; Wang D; Tang O; McEvoy JW; Echouffo-Tcheugui JB; Christenson RH; Selvin E
J Am Heart Assoc; 2023 Jun; 12(11):e029083. PubMed ID: 37254959
[TBL] [Abstract][Full Text] [Related]
3. Associations of N-terminal pro-B-type natriuretic peptide, estimated glomerular filtration rate, and mortality in US adults.
Ozkan B; Grams ME; Coresh J; McEvoy JW; Echouffo-Tcheugui JB; Mu SZ; Tang O; Daya NR; Kim H; Christenson RH; Ndumele CE; Selvin E
Am Heart J; 2023 Oct; 264():49-58. PubMed ID: 37290699
[TBL] [Abstract][Full Text] [Related]
4. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
[TBL] [Abstract][Full Text] [Related]
5. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
8. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study.
Hussain A; Sun W; Deswal A; de Lemos JA; McEvoy JW; Hoogeveen RC; Matsushita K; Aguilar D; Bozkurt B; Virani SS; Shah AM; Selvin E; Ndumule C; Ballantyne CM; Nambi V
J Am Coll Cardiol; 2021 Feb; 77(5):559-571. PubMed ID: 33538254
[TBL] [Abstract][Full Text] [Related]
9. Associations of Cardiac Biomarkers With Peripheral Artery Disease and Peripheral Neuropathy in US Adults Without Prevalent Cardiovascular Disease.
Hicks CW; Wang D; McDermott K; Matsushita K; Tang O; Echouffo-Tcheugui JB; McEvoy JW; Christenson RH; Selvin E
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1583-1591. PubMed ID: 37317848
[TBL] [Abstract][Full Text] [Related]
10. Association of N-terminal pro-brain natriuretic peptide with survival among US cancer survivors.
Cao C; Yang L; Nohria A; Mayer EL; Partridge AH; Ligibel JA
J Natl Cancer Inst; 2024 Jun; 116(6):938-947. PubMed ID: 38299668
[TBL] [Abstract][Full Text] [Related]
11. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
12. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Elevated NT-proBNP and its Prognostic Value by Blood Pressure Treatment and Control.
Daya NR; McEvoy JW; Christenson RH; Tang O; Foti K; Juraschek SP; Selvin E; Echouffo-Tcheugui JB
Am J Hypertens; 2023 Oct; 36(11):602-611. PubMed ID: 37458697
[TBL] [Abstract][Full Text] [Related]
14. N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study.
Ezekowitz JA; O'Connor CM; Troughton RW; Alemayehu WG; Westerhout CM; Voors AA; Butler J; Lam CSP; Ponikowski P; Emdin M; Patel MJ; Pieske B; Roessig L; Hernandez AF; Armstrong PW
JACC Heart Fail; 2020 Nov; 8(11):931-939. PubMed ID: 33039447
[TBL] [Abstract][Full Text] [Related]
15. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
Eggers KM; Venge P; Lind L
Am J Cardiol; 2013 Jan; 111(1):131-6. PubMed ID: 23040598
[TBL] [Abstract][Full Text] [Related]
16. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
[TBL] [Abstract][Full Text] [Related]
17. Elevated NT-ProBNP as a Cardiovascular Disease Risk Equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) Study.
Tcheugui JB; Zhang S; McEvoy JW; Ndumele CE; Hoogeveen RC; Coresh J; Selvin E
Am J Med; 2022 Dec; 135(12):1461-1467. PubMed ID: 36007589
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in the Prognostic Power of Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide for Cardiovascular Events - The Japan Morning Surge-Home Blood Pressure Study.
Taki M; Ishiyama Y; Mizuno H; Komori T; Kono K; Hoshide S; Kario K
Circ J; 2018 Jul; 82(8):2096-2102. PubMed ID: 29925742
[TBL] [Abstract][Full Text] [Related]
19. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients.
Shadman R; Allison MA; Criqui MH
J Am Coll Cardiol; 2007 Jun; 49(22):2172-81. PubMed ID: 17543637
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population.
Mirza SS; de Bruijn RF; Koudstaal PJ; van den Meiracker AH; Franco OH; Hofman A; Tiemeier H; Ikram MA
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):356-62. PubMed ID: 25918047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
